Peritoneal Surface Cancers (PSC) affect the lining of the abdominal cavity (the peritoneum). Just a decade ago, these cancers were considered incurable. Today, with advancements like Cytoreductive Surgery (CRS) and HIPEC (Hyperthermic Intraperitoneal Chemotherapy), long-term survival—even cure—is possible in carefully selected patients.
This transformation is backed by high-quality scientific evidence and expert surgical techniques.
Some common cancers can seed the peritoneal lining, including:
Regardless of the origin, the treatment strategy remains the same:
Cytoreductive Surgery (CRS) + HIPEC
Peritoneal cancers often present subtly at first. Common signs include:
If you or a loved one experience these symptoms, early evaluation is crucial.
A thorough workup includes:
Each patient is discussed in a multidisciplinary tumor board to ensure personalized care.
Typically 3–4 cycles of intravenous chemotherapy are given first to shrink tumor burden and optimize the patient’s fitness for surgery.
A complex, high-precision surgery performed by experts
The goal: complete removal of all visible cancer across the abdominal cavity, including affected organs or bowel segments
This is followed by HIPEC – heated, high-dose chemotherapy circulated within the abdomen during surgery to destroy microscopic cancer cells
Patients are closely monitored in the ICU for 48 hours post-surgery for a safe and smooth recovery
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a minimally invasive technique that delivers aerosolized chemotherapy into the abdomen using laparoscopy.
You don’t have to go through it alone. The journey is complex, but with expert care and advanced treatment, hope is very much alive.
Consultant Surgical Oncologist & Peritoneal Surface Oncologist
HIPEC & PIPAC Specialist
Book a consultation to explore treatment options that go beyond conventional cancer care.